Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3Phase 4 2Phase 1/2 2Phase NA 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Promyelocytic, Acute 2Recurrence 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Arsenic Trioxide × Clear all
NCT01987297 2019-08-19

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
738 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00196768 2007-10-23

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

German AML Cooperative Group

Phase 4 Unknown
30 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡